Skip to main content
Top
Published in: Inflammation 5/2014

01-10-2014

Gabapentin, a Synthetic Analogue of Gamma Aminobutyric Acid, Reverses Systemic Acute Inflammation and Oxidative Stress in Mice

Authors: Jordana Maia Dias, Tarcisio Vieira de Brito, Diva de Aguiar Magalhães, Pammela Weryka da Silva Santos, Jalles Arruda Batista, Eulina Gabriela do Nascimento Dias, Heliana de Barros Fernandes, Samara Rodrigues Bonfim Damasceno, Renan O. Silva, Karoline S. Aragão, Marcellus H. L. P. Souza, Jand-Venes R. Medeiros, André Luiz R. Barbosa

Published in: Inflammation | Issue 5/2014

Login to get access

Abstract

The aim of this study was to investigate the potential anti-inflammatory and anti-oxidant effects of gabapentin (GBP) in mice. The anti-inflammatory and anti-oxidant effects were evaluated using various mediators that induce paw edema, peritonitis model, myeloperoxidase (MPO) activity, proinflammatory cytokine levels, glutathione (GSH) consumption, and malondialdehyde (MDA) production in mice. Pretreatment of mice with GBP (1 mg/kg) significantly reduced carrageenan or dextran-induced paw edema (P < 0.05) when compared to vehicle group. Adding to this, GBP (1 mg/kg) significantly inhibited paw edema induced by histamine, serotonin, bradikinin, 48/80 compound, and prostaglandin E2. In the carrageenan-induced peritonitis model, GBP significantly decreased total and differential leukocyte counts and reduced the levels of MPO activity in the plantar tissue and IL-1β and TNF-α concentrations in the peritoneal exudate. The same dose of GBP also decreased the MDA concentration and increased the levels of GSH into the peritoneal fluid. In summary, our results demonstrated that GBP exhibited anti-inflammatory activity in mice by reducing the action of inflammatory mediators, neutrophil migration and proinflammatory cytokine levels, and anti-oxidant properties by decreasing the concentration of MDA and increasing the GSH content. These observations raise the possibility that GBP could be used to improve tissue resistance to damage during inflammatory conditions.
Literature
1.
go back to reference Shimoyama, M., N. Shimoyama, C.E. Inturrisi, and K.J. Elliott. 1997. Gabapentin enhances the antinociceptive effects of spinal morphine in the rat tail-flick test. Pain 72: 375–382.PubMedCrossRef Shimoyama, M., N. Shimoyama, C.E. Inturrisi, and K.J. Elliott. 1997. Gabapentin enhances the antinociceptive effects of spinal morphine in the rat tail-flick test. Pain 72: 375–382.PubMedCrossRef
2.
go back to reference Hwang, J.H., and T.L. Yaksh. 1997. Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the rat. Reg Anesth 22: 249–256.PubMedCrossRef Hwang, J.H., and T.L. Yaksh. 1997. Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the rat. Reg Anesth 22: 249–256.PubMedCrossRef
3.
go back to reference Backonja, M., A. Beydoun, K.R. Edwards, S.L. Schwartz, V. Fonseca, M. Hes, L. La Moreaux, and E. Garofalo. 1998. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA b280: 1831–1836.CrossRef Backonja, M., A. Beydoun, K.R. Edwards, S.L. Schwartz, V. Fonseca, M. Hes, L. La Moreaux, and E. Garofalo. 1998. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA b280: 1831–1836.CrossRef
4.
go back to reference Singh, D., and D.H. Kennedy. 2003. The use of gabapentin for the treatment of postherpetic neuralgia. Clin Ther 25: 852–889.PubMedCrossRef Singh, D., and D.H. Kennedy. 2003. The use of gabapentin for the treatment of postherpetic neuralgia. Clin Ther 25: 852–889.PubMedCrossRef
5.
go back to reference Pöllmann, W., and W. Feneberg. 2008. Current management of pain associated with multiple sclerosis. CNS Drugs 22: 291–324.PubMedCrossRef Pöllmann, W., and W. Feneberg. 2008. Current management of pain associated with multiple sclerosis. CNS Drugs 22: 291–324.PubMedCrossRef
6.
go back to reference Abdel-Salam, O.M.E., and A.A. Sleem. 2009. Study of the analgesic, anti-inflammatory, and gastric effects of gabapentin. Drug Discov Ther 3: 18–26.PubMed Abdel-Salam, O.M.E., and A.A. Sleem. 2009. Study of the analgesic, anti-inflammatory, and gastric effects of gabapentin. Drug Discov Ther 3: 18–26.PubMed
7.
go back to reference Silva, V.G., R.O. Silva, S.R. Damasceno, N.S. Carvalho, R.S. Prudêncio, K.S. Aragão, M.A. Guimarães, S.A. Campos, L.M. Véras, M. Godejohann, J.R. Leite, A.L. Barbosa, and J.V. Medeiros. 2013. Anti-inflammatory and antinociceptive activity of epiisopiloturine, an imidazole alkaloid isolated from Pilocarpus microphyllus. J Nat Prod 76: 1071–1077.PubMedCrossRef Silva, V.G., R.O. Silva, S.R. Damasceno, N.S. Carvalho, R.S. Prudêncio, K.S. Aragão, M.A. Guimarães, S.A. Campos, L.M. Véras, M. Godejohann, J.R. Leite, A.L. Barbosa, and J.V. Medeiros. 2013. Anti-inflammatory and antinociceptive activity of epiisopiloturine, an imidazole alkaloid isolated from Pilocarpus microphyllus. J Nat Prod 76: 1071–1077.PubMedCrossRef
8.
go back to reference Vinegar, R., J.F. Truax, J.L. Selph, P.R. Johnston, A.L. Venable, and K.K. McKenzie. 1987. Pathway to carrageenan-induced inflammation in the hind limb of the rat. Fed Proc 46: 118–126.PubMed Vinegar, R., J.F. Truax, J.L. Selph, P.R. Johnston, A.L. Venable, and K.K. McKenzie. 1987. Pathway to carrageenan-induced inflammation in the hind limb of the rat. Fed Proc 46: 118–126.PubMed
9.
go back to reference Carvalho, W.A., and L. Lemônica. 1998. Mecanismos celulares e moleculares da dor inflamatória. Rev Bras Anestesiol 48: 137–158. Carvalho, W.A., and L. Lemônica. 1998. Mecanismos celulares e moleculares da dor inflamatória. Rev Bras Anestesiol 48: 137–158.
10.
go back to reference Greer, C.W., I. Shomera, M.E. Goldsteinb, and W. Yaphe. 1984. Analysis of carrageenan from Hypnea musciformis by using κ- and ι-carrageenases and 13C-N.M.R. spectroscopy. Carbohydr Res 129: 189–196.CrossRef Greer, C.W., I. Shomera, M.E. Goldsteinb, and W. Yaphe. 1984. Analysis of carrageenan from Hypnea musciformis by using κ- and ι-carrageenases and 13C-N.M.R. spectroscopy. Carbohydr Res 129: 189–196.CrossRef
11.
go back to reference Aziza, M., T. Givernaud, M. Chikhaoui-khay, and L. Bennasser. 2008. Seasonal variation of the growth, chemical composition and carrageenan extracted from Hypnea musciformis (Wulfen) Lamouroux harvested along the Atlantic coast of Morocco. Sci Res Essays 2: 509–514. Aziza, M., T. Givernaud, M. Chikhaoui-khay, and L. Bennasser. 2008. Seasonal variation of the growth, chemical composition and carrageenan extracted from Hypnea musciformis (Wulfen) Lamouroux harvested along the Atlantic coast of Morocco. Sci Res Essays 2: 509–514.
12.
go back to reference Carvalho, J.C., J.R. Teixeira, P.J. Souza, J.K. Bastos, D. dos Santos Filho, and S.J. Sarti. 1996. Preliminary studies of analgesic and anti-inflammatory properties of Caesalpinea ferrea crude extract. J Ethnopharmacol 53: 175–178.PubMedCrossRef Carvalho, J.C., J.R. Teixeira, P.J. Souza, J.K. Bastos, D. dos Santos Filho, and S.J. Sarti. 1996. Preliminary studies of analgesic and anti-inflammatory properties of Caesalpinea ferrea crude extract. J Ethnopharmacol 53: 175–178.PubMedCrossRef
13.
go back to reference Hajare, S.W., S. Chandra, J. Sharma, S.K. Tandan, J. Lal, and A.G. Telang. 2001. Anti-inflammatory activity of Dalbergia sissoo leaves. Fitoterapia 72: 131–139.PubMedCrossRef Hajare, S.W., S. Chandra, J. Sharma, S.K. Tandan, J. Lal, and A.G. Telang. 2001. Anti-inflammatory activity of Dalbergia sissoo leaves. Fitoterapia 72: 131–139.PubMedCrossRef
14.
go back to reference Srinivasan, K., S. Muruganandan, J. Lal, S. Chandra, S.K. Tandan, and V.R. Prakash. 2001. Evaluation of anti-inflammatory activity of Pongamia pinnata leaves in rats. J Ethnopharmacol 78: 151–157.PubMedCrossRef Srinivasan, K., S. Muruganandan, J. Lal, S. Chandra, S.K. Tandan, and V.R. Prakash. 2001. Evaluation of anti-inflammatory activity of Pongamia pinnata leaves in rats. J Ethnopharmacol 78: 151–157.PubMedCrossRef
15.
go back to reference Calixto, J.B., M.M. Campos, M.F. Otuki, and A.R. Santos. 2004. Anti-inflammatory compounds of plant origin. Part II. Modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med 70: 93–103.PubMedCrossRef Calixto, J.B., M.M. Campos, M.F. Otuki, and A.R. Santos. 2004. Anti-inflammatory compounds of plant origin. Part II. Modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med 70: 93–103.PubMedCrossRef
16.
go back to reference Lanhers, M.C., J. Fleurentin, P. Dorfman, F. Mortier, and J.M. Pelt. 1991. Analgesic, antipyretic and anti-inflammatory properties of Euphorbia hirta. Planta Med 57: 225–231.PubMedCrossRef Lanhers, M.C., J. Fleurentin, P. Dorfman, F. Mortier, and J.M. Pelt. 1991. Analgesic, antipyretic and anti-inflammatory properties of Euphorbia hirta. Planta Med 57: 225–231.PubMedCrossRef
17.
go back to reference Mihara, M., and M. Uchiyama. 1978. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Ana Biochem 86: 271–278.CrossRef Mihara, M., and M. Uchiyama. 1978. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Ana Biochem 86: 271–278.CrossRef
18.
go back to reference Sedlak, J., and R.H. Lindsay. 1968. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 24: 1992–2005. Sedlak, J., and R.H. Lindsay. 1968. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 24: 1992–2005.
19.
go back to reference Jensen, A.A., J. Mosbacher, S. Elg, K. Lingenhoehl, T. Lohmann, T.N. Johansen, B. Abrahamsen, J.P. Mattsson, A. Lehmann, B. Bettler, and H. Bräuner-Osborne. 2002. The anticonvulsant gabapentin (neurontin) does not act through gamma-aminobutyric acid-B receptors. Mol Pharmacol 6: 1377–1384.CrossRef Jensen, A.A., J. Mosbacher, S. Elg, K. Lingenhoehl, T. Lohmann, T.N. Johansen, B. Abrahamsen, J.P. Mattsson, A. Lehmann, B. Bettler, and H. Bräuner-Osborne. 2002. The anticonvulsant gabapentin (neurontin) does not act through gamma-aminobutyric acid-B receptors. Mol Pharmacol 6: 1377–1384.CrossRef
20.
go back to reference Bennett, M.I., and K.H. Simpson. 2004. Gabapentin in the treatment of neuropathic pain. Palliat Med 18: 5–11.PubMedCrossRef Bennett, M.I., and K.H. Simpson. 2004. Gabapentin in the treatment of neuropathic pain. Palliat Med 18: 5–11.PubMedCrossRef
21.
go back to reference Abdi, S., D.H. Lee, and J.M. Chung. 1998. The anti-allodynic effects of amitriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain. Anesth Analg 87: 1360–1366.PubMed Abdi, S., D.H. Lee, and J.M. Chung. 1998. The anti-allodynic effects of amitriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain. Anesth Analg 87: 1360–1366.PubMed
22.
go back to reference Yasuda, T., S. Miki, N. Yoshinaga, and E. Senba. 2005. Effects of amitriptyline and gabapentin on bilateral hyperalgesia observed in an animal model of unilateral axotomy. Pain 115: 161–170.PubMedCrossRef Yasuda, T., S. Miki, N. Yoshinaga, and E. Senba. 2005. Effects of amitriptyline and gabapentin on bilateral hyperalgesia observed in an animal model of unilateral axotomy. Pain 115: 161–170.PubMedCrossRef
23.
go back to reference Shimoyama, N., M. Shimoyama, A.M. Davis, C.E. Inturrisi, and K.J. Elliott. 1997. Spinal gabapentin is antinociceptive in the rat formalin test. Neurosci Lett 222: 65–67.PubMedCrossRef Shimoyama, N., M. Shimoyama, A.M. Davis, C.E. Inturrisi, and K.J. Elliott. 1997. Spinal gabapentin is antinociceptive in the rat formalin test. Neurosci Lett 222: 65–67.PubMedCrossRef
24.
go back to reference Hunter, J.C., K.R. Gogas, L.R. Hedley, L.O. Jacobson, L. Kassotakis, J. Thompson, and D.J. Fontana. 1997. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur J Pharmacol 324: 153–160.PubMedCrossRef Hunter, J.C., K.R. Gogas, L.R. Hedley, L.O. Jacobson, L. Kassotakis, J. Thompson, and D.J. Fontana. 1997. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur J Pharmacol 324: 153–160.PubMedCrossRef
25.
go back to reference Vinegar, R., W. Schreiber, and R. Hugo. 1969. Biphasic development of carrageenin edema in rats. J Pharmacol Exp Ther 166: 96–103.PubMed Vinegar, R., W. Schreiber, and R. Hugo. 1969. Biphasic development of carrageenin edema in rats. J Pharmacol Exp Ther 166: 96–103.PubMed
26.
go back to reference de Brito, T.V., R.S. Prudêncio, A.B.. Sales, F. Vieira Jr., S.J. Candeira, Á.X. Franco, K.S. Aragão, R.A. Ribeiro, Ponte de Souza MH, L.S. Chaves, A.L. Freitas, J.V. Medeiros, and A.L.R. Barbosa. 2013. Anti-inflammatory effect of a sulphated polysaccharide fraction extracted from the red algae Hypnea musciformis via the suppression of neutrophil migration by the nitric oxide signalling pathway. J Pharm Pharmacol 65: 724–733. de Brito, T.V., R.S. Prudêncio, A.B.. Sales, F. Vieira Jr., S.J. Candeira, Á.X. Franco, K.S. Aragão, R.A. Ribeiro, Ponte de Souza MH, L.S. Chaves, A.L. Freitas, J.V. Medeiros, and A.L.R. Barbosa. 2013. Anti-inflammatory effect of a sulphated polysaccharide fraction extracted from the red algae Hypnea musciformis via the suppression of neutrophil migration by the nitric oxide signalling pathway. J Pharm Pharmacol 65: 724–733.
27.
go back to reference Dawson, J., A.D. Sedgwick, J.C.W. Edwards, and P. Lees. 1991. A comparative study of the cellular, exudative and histological responses to carrageenan, dextran and zymosan in the mouse. Inter J Tissue Reac 13–14: 171–185. Dawson, J., A.D. Sedgwick, J.C.W. Edwards, and P. Lees. 1991. A comparative study of the cellular, exudative and histological responses to carrageenan, dextran and zymosan in the mouse. Inter J Tissue Reac 13–14: 171–185.
28.
go back to reference Cragg, G.M., D.J. Newman, and K.M. Snader. 1997. Natural products in drug discovery and development. J Nat Prod 60: 52–60.PubMedCrossRef Cragg, G.M., D.J. Newman, and K.M. Snader. 1997. Natural products in drug discovery and development. J Nat Prod 60: 52–60.PubMedCrossRef
29.
go back to reference De Smet, P.A. 2007. The role of plant-derived drugs and herbal medicines in healthcare. Drugs 54: 801–840.CrossRef De Smet, P.A. 2007. The role of plant-derived drugs and herbal medicines in healthcare. Drugs 54: 801–840.CrossRef
30.
go back to reference Rowley, D.A., and E.P. Benditt. 1956. 5-hydroxytryptamine and histamine as mediators of the vascular injury produced by agents which damage mast cells in rats. J Exp Med 103: 399–415.PubMedCrossRefPubMedCentral Rowley, D.A., and E.P. Benditt. 1956. 5-hydroxytryptamine and histamine as mediators of the vascular injury produced by agents which damage mast cells in rats. J Exp Med 103: 399–415.PubMedCrossRefPubMedCentral
31.
go back to reference Kulkarni, S.K., A.K. Mehta, and J. Kunchandy. 1986. Anti-inflammatory actions of clonidine, guanfacine and B-HT 920 against various inflammagen-induced acute paw oedema in rats. Arch Int Pharmacodyn Ther 279: 324–334.PubMed Kulkarni, S.K., A.K. Mehta, and J. Kunchandy. 1986. Anti-inflammatory actions of clonidine, guanfacine and B-HT 920 against various inflammagen-induced acute paw oedema in rats. Arch Int Pharmacodyn Ther 279: 324–334.PubMed
32.
go back to reference Seibert, K., Y. Zhang, K. Leahy, S. Hauser, J. Masferrer, W. Perkins, L. Lee, and P. Isakson. 1994. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci 91: 12013–12017.PubMedCrossRefPubMedCentral Seibert, K., Y. Zhang, K. Leahy, S. Hauser, J. Masferrer, W. Perkins, L. Lee, and P. Isakson. 1994. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci 91: 12013–12017.PubMedCrossRefPubMedCentral
33.
go back to reference Lago, J., A. Alfonso, M.R. Vieytes, and L.M. Botana. 2001. Ouabain-induced enhancement of rat mast cells response. Modulation by protein phosphorylation and intracellular pH. Cell Signal 13: 515–524.PubMedCrossRef Lago, J., A. Alfonso, M.R. Vieytes, and L.M. Botana. 2001. Ouabain-induced enhancement of rat mast cells response. Modulation by protein phosphorylation and intracellular pH. Cell Signal 13: 515–524.PubMedCrossRef
34.
go back to reference Okazaki, T., V.S. Ilea, A. Okazaki, K. Wicher, R.E. Reisman, and C.E. Arbesman. 1976. Inhibition of antigen-induced histamine release by ouabain. J Allergy Clin Immunol 57: 454–462.PubMedCrossRef Okazaki, T., V.S. Ilea, A. Okazaki, K. Wicher, R.E. Reisman, and C.E. Arbesman. 1976. Inhibition of antigen-induced histamine release by ouabain. J Allergy Clin Immunol 57: 454–462.PubMedCrossRef
35.
go back to reference Senol, M., I.H. Ozerol, A.V. Patel, and D.P. Skoner. 2007. The effect of Na+-K+ATPase inhibition by ouabain on histamine release from human cutaneous mast cells. Mol Cell Biochem 294: 25–29.PubMedCrossRef Senol, M., I.H. Ozerol, A.V. Patel, and D.P. Skoner. 2007. The effect of Na+-K+ATPase inhibition by ouabain on histamine release from human cutaneous mast cells. Mol Cell Biochem 294: 25–29.PubMedCrossRef
36.
go back to reference Ajuebor, M.N., A. Singh, and J.L. Wallace. 2000. Cyclooxygenase-2-derived prostaglandin D2 is an early anti-inflammatory signal in experimental colitis. J Physiol Gastrointest Liver Physiol 279: 238–244. Ajuebor, M.N., A. Singh, and J.L. Wallace. 2000. Cyclooxygenase-2-derived prostaglandin D2 is an early anti-inflammatory signal in experimental colitis. J Physiol Gastrointest Liver Physiol 279: 238–244.
37.
go back to reference Souza, G.E., F.Q. Cunha, R. Mello, and S.H. Ferreira. 1988. Neutrophil migration induced by inflammatory stimuli is reduced by macrophage depletion. Agents Actions 24: 377–380.PubMedCrossRef Souza, G.E., F.Q. Cunha, R. Mello, and S.H. Ferreira. 1988. Neutrophil migration induced by inflammatory stimuli is reduced by macrophage depletion. Agents Actions 24: 377–380.PubMedCrossRef
38.
go back to reference Klebanoff, S.J. 1999. Myeloperoxidase. Proc. Assoc. Am. Physicians 111: 383–389.PubMed Klebanoff, S.J. 1999. Myeloperoxidase. Proc. Assoc. Am. Physicians 111: 383–389.PubMed
39.
go back to reference Gupta, M., U.K. Mazumdar, T. Sivakumar, M.L. Vamsi, S.S. Karki, R. Sambathkumar, and L. Manikandan. 2003. Evaluation of anti-inflammatory activity of chloroform extract of Bryonia laciniosa in experimental animal models. Biol Pharm Bull 26: 1342–1344.PubMedCrossRef Gupta, M., U.K. Mazumdar, T. Sivakumar, M.L. Vamsi, S.S. Karki, R. Sambathkumar, and L. Manikandan. 2003. Evaluation of anti-inflammatory activity of chloroform extract of Bryonia laciniosa in experimental animal models. Biol Pharm Bull 26: 1342–1344.PubMedCrossRef
40.
go back to reference Chaves, L.S., L.A. Nicolau, R.O. Silva, F.C. Barros, A.L. Freitas, K.S. Aragão, R.A. Ribeiro, M.H. Souza, A.L. Barbosa, and J.V. Medeiros. 2013. Antiinflammatory and antinociceptive effects in mice of a sulfated polysaccharide fraction extracted from the marine red algae Gracilaria caudate. Immunopharmacol Immunotoxicol 35: 93–100.CrossRef Chaves, L.S., L.A. Nicolau, R.O. Silva, F.C. Barros, A.L. Freitas, K.S. Aragão, R.A. Ribeiro, M.H. Souza, A.L. Barbosa, and J.V. Medeiros. 2013. Antiinflammatory and antinociceptive effects in mice of a sulfated polysaccharide fraction extracted from the marine red algae Gracilaria caudate. Immunopharmacol Immunotoxicol 35: 93–100.CrossRef
41.
42.
go back to reference Sutbeyaz, Y., B. Yakan, H. Ozdemir, M. Karasen, F. Doner, and I. Kufrevioglu. 1996. Effect of SC-41930, a potent selective leukotriene B4 receptor antagonist, in the guinea pig model of middle ear inflammation. Ann Otol Rhinol Laryngol 105: 476–480.PubMed Sutbeyaz, Y., B. Yakan, H. Ozdemir, M. Karasen, F. Doner, and I. Kufrevioglu. 1996. Effect of SC-41930, a potent selective leukotriene B4 receptor antagonist, in the guinea pig model of middle ear inflammation. Ann Otol Rhinol Laryngol 105: 476–480.PubMed
43.
go back to reference Josse, C., J.R. Boelaert, M. Best-Belpomme, and J. Piette. 2001. Importance of post-transcriptional regulation of chemokine genes by oxidative stress. Biochem J 360: 321–333.PubMedCrossRefPubMedCentral Josse, C., J.R. Boelaert, M. Best-Belpomme, and J. Piette. 2001. Importance of post-transcriptional regulation of chemokine genes by oxidative stress. Biochem J 360: 321–333.PubMedCrossRefPubMedCentral
44.
go back to reference Cuzzocrea, S., D.P. Riley, A.P. Caputi, and D. Salvemini. 2001. Antioxidant therapy: a new pharmacological approach in shock, inflammation and ischemia/reperfusion injury. Pharmacol Rev 53: 135–159.PubMed Cuzzocrea, S., D.P. Riley, A.P. Caputi, and D. Salvemini. 2001. Antioxidant therapy: a new pharmacological approach in shock, inflammation and ischemia/reperfusion injury. Pharmacol Rev 53: 135–159.PubMed
45.
go back to reference Amirshahrokhi, K., S. Bohlooli, and M.M. Chinifroush. 2011. The effect of methylsulfonylmethane on the experimental colitis in the rat. T Appl Pharmacol 253: 197–202.CrossRef Amirshahrokhi, K., S. Bohlooli, and M.M. Chinifroush. 2011. The effect of methylsulfonylmethane on the experimental colitis in the rat. T Appl Pharmacol 253: 197–202.CrossRef
Metadata
Title
Gabapentin, a Synthetic Analogue of Gamma Aminobutyric Acid, Reverses Systemic Acute Inflammation and Oxidative Stress in Mice
Authors
Jordana Maia Dias
Tarcisio Vieira de Brito
Diva de Aguiar Magalhães
Pammela Weryka da Silva Santos
Jalles Arruda Batista
Eulina Gabriela do Nascimento Dias
Heliana de Barros Fernandes
Samara Rodrigues Bonfim Damasceno
Renan O. Silva
Karoline S. Aragão
Marcellus H. L. P. Souza
Jand-Venes R. Medeiros
André Luiz R. Barbosa
Publication date
01-10-2014
Publisher
Springer US
Published in
Inflammation / Issue 5/2014
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-014-9913-2

Other articles of this Issue 5/2014

Inflammation 5/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.